X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (518) 518
transplantation (350) 350
epstein-barr virus (332) 332
male (318) 318
post-transplant lymphoproliferative disorder (317) 317
index medicus (303) 303
female (267) 267
adult (210) 210
lymphoproliferative disorders - etiology (196) 196
post-transplant lymphoproliferative disease (194) 194
disease (187) 187
immunosuppression (185) 185
epstein-barr-virus (174) 174
middle aged (172) 172
child (163) 163
recipients (147) 147
rituximab (145) 145
pediatrics (143) 143
adolescent (141) 141
risk factors (132) 132
hematology (130) 130
surgery (125) 125
lymphoma (121) 121
post‐transplant lymphoproliferative disorder (117) 117
epstein–barr virus (116) 116
lymphoproliferative disorders - virology (112) 112
child, preschool (106) 106
children (103) 103
lymphomas (101) 101
oncology (101) 101
health aspects (100) 100
kidney transplantation (100) 100
aged (97) 97
retrospective studies (95) 95
kidney transplantation - adverse effects (93) 93
lymphoproliferative disorders - diagnosis (89) 89
immunosuppressive agents - therapeutic use (85) 85
epstein-barr virus infections - complications (83) 83
therapy (83) 83
immunotherapy (81) 81
infant (81) 81
liver transplantation (80) 80
organ transplant recipients (79) 79
post-transplant lymphoproliferative disorders (79) 79
treatment outcome (78) 78
viral load (76) 76
hemic and lymphatic diseases (75) 75
solid-organ transplantation (74) 74
immunology (73) 73
risk (72) 72
lymphoproliferative disorders - therapy (71) 71
herpesvirus 4, human - isolation & purification (70) 70
infection (69) 69
ebv (67) 67
post‐transplant lymphoproliferative disease (67) 67
ptld (67) 67
posttransplant lymphoproliferative disorders (66) 66
medicine & public health (65) 65
prognosis (65) 65
lymphoproliferative disorders - pathology (64) 64
stem cells (63) 63
transplantation of organs, tissues, etc (61) 61
cancer (60) 60
chemotherapy (60) 60
lymphoproliferative disorders (60) 60
transplants & implants (60) 60
incidence (59) 59
immunosuppressive agents - adverse effects (58) 58
kidneys (58) 58
epstein-barr virus infections - diagnosis (57) 57
liver transplantation - adverse effects (57) 57
lymphocytes (57) 57
postoperative complications (57) 57
risk-factors (57) 57
care and treatment (56) 56
lymphoproliferative disorders - drug therapy (56) 56
pathology (56) 56
diagnosis (55) 55
epstein-barr virus infections - virology (55) 55
lymphoproliferative disorders - immunology (55) 55
surgical procedures, operative (55) 55
disorders (54) 54
hematopoietic stem cells (54) 54
organ transplantation - adverse effects (54) 54
analysis (53) 53
follow-up studies (53) 53
young adult (53) 53
stem-cell transplantation (52) 52
lymphoproliferative disorders - epidemiology (51) 51
time factors (51) 51
herpesvirus 4, human - genetics (49) 49
renal-transplantation (48) 48
liver (47) 47
posttransplant lymphoproliferative disorder (46) 46
bone-marrow-transplantation (45) 45
peripheral-blood (45) 45
polymerase chain reaction (45) 45
epstein‐barr virus (43) 43
liver-transplantation (43) 43
organ transplantation (42) 42
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (808) 808
French (14) 14
German (10) 10
Polish (6) 6
Spanish (6) 6
Japanese (5) 5
Korean (3) 3
Hungarian (2) 2
Turkish (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, ISSN 1130-0108, 02/2018, Volume 110, Issue 2, pp. 131 - 132
We have read the article "Post-transplant lymphoproliferative disease in liver transplant recipients" with great interest. This article reports a series of... 
Non-Hodgkin lymphoma | Rituximab | Post-transplant lymphoproliferative disease | GASTROENTEROLOGY & HEPATOLOGY | Liver transplantation
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2015, Volume 34, Issue 11, pp. 1406 - 1414
Journal Article
Journal Article
Current opinion in hematology, ISSN 1065-6251, 11/2014, Volume 21, Issue 6, pp. 476 - 481
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 06/2015, Volume 21, Issue 6, pp. 604.e1 - 604.e9
Journal Article
European Journal of Haematology, ISSN 0902-4441, 02/2016, Volume 96, Issue 2, pp. 128 - 135
We report the outcome of 30 consecutive patients with Hodgkin disease (HD) who underwent single‐unit UCBT. Most (90%) patients had failed previous autologous... 
EBV post‐transplant lymphoproliferative disease | umbilical cord blood transplantation | Hodgkin's disease | Hodgkin's lymphoma | EBV post-transplant lymphoproliferative disease | Umbilical cord blood transplantation | PREPARATIVE REGIMEN | UNRELATED DONORS | BRENTUXIMAB VEDOTIN | LYMPHOMA WORKING PARTY | EUROPEAN GROUP | THERAPY | MALIGNANCIES | MARROW-TRANSPLANTATION | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Myeloablative Agonists - therapeutic use | Thiotepa - therapeutic use | Recurrence | Infectious Mononucleosis - immunology | Hodgkin Disease - pathology | Infectious Mononucleosis - etiology | Humans | Middle Aged | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Cord Blood Stem Cell Transplantation - adverse effects | Graft vs Host Disease - mortality | Antilymphocyte Serum - therapeutic use | Hodgkin Disease - mortality | Adult | Female | Herpesvirus 4, Human - pathogenicity | Acute Disease | Busulfan - therapeutic use | Infectious Mononucleosis - pathology | Graft Survival | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Infectious Mononucleosis - mortality | Graft vs Host Disease - pathology | Hodgkin Disease - therapy | Survival Analysis | Graft vs Host Disease - prevention & control | Hodgkin Disease - immunology | Transplantation Conditioning | Chronic Disease | Adults
Journal Article
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 10/2019, Volume 10
Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) is a life-threatening complication of T-lymphocyte deplete allogeneic... 
Usage | Epstein-Barr virus diseases | Transplantation | Research | Diagnosis | T cells | Drug therapy | Risk factors | Hematopoietic stem cells | Epstein-Barr virus | Stem cells | T-cells | PTLD | donor lymphocyte infusion | post-transplant lymphoproliferative disease | adoptive T-cell therapy
Journal Article
by Hyun, H and Park, E and Cho, M and Min, SI and Ha, J and Kang, HJ and Shin, HY and Ha, IS and Cheong, HI and Ahn, YH and Kang, HG
JOURNAL OF KOREAN MEDICAL SCIENCE, ISSN 1011-8934, 08/2019, Volume 34, Issue 30, pp. e203 - 13
Background: Post-transplant lymphoproliferative disease (PTLD) is one of the major complications of organ transplantation, especially in children with... 
SOLID-ORGAN TRANSPLANTATION | VIRAL LOAD | PTLD RISK | Epstein-Barr Virus | PREEMPTIVE RITUXIMAB | Rituximab | DISORDERS | Kidney Transplantation | RENAL-TRANSPLANTATION | ADULT | MEDICINE, GENERAL & INTERNAL | Post-Transplant Lymphoproliferative Disease | INFECTION | EPIDEMIOLOGY | EB VIRUS | 의학일반
Journal Article
Journal Article